A physical examination package with a group purchase price of 1056 yuan has the embarrassment of "finding the disease in the morning and recovering in the afternoon".

　　In November this year, Ms. Chen from Shanghai bought a health check-up package for middle-aged and elderly people with a price of 1056 yuan online, and made an appointment for a physical examination at the store by telephone according to the group purchase instructions. The contents of this physical examination include internal medicine, surgery, tumor markers, 11 items of liver function and 3 items of renal function.

　　"On the website, the cheapest medical examination package is only three or four hundred yuan, the expensive one is 1,500 yuan, and the middle-aged and elderly package of 1,056 yuan is above average." Ms. Chen is 32 years old. She told reporters that she has compared the packages of many well-known medical institutions such as ikang, Mei Nianda Health and Ruici Physical Examination. The price of 1,056 yuan does not belong to the ranks of "low-cost medical examination" in any medical examination center. "I specially chose expensive ones to make the institutions earn enough money, so I should never be cheated again."

　　However, later facts proved that she was wrong.

　　The physical examination report is inconsistent with the examination results of the top three hospitals.

　　During the physical examination, the "doctor" who did the neck B-ultrasound told Ms. Chen that her thyroid was "bad" and had serious inflammation. The B-ultrasound report showed that there was a serious "diffuse echo" in the thyroid gland. The "doctor" reminded Ms. Chen, "Go to Shou Feitai on the first floor and have a blood test of thyroid function. You don’t need to draw blood again, just pay."

　　During the surgical examination, the surgical "doctor" touched the thyroid gland of Ms. Chen’s neck and reminded her again, "You can already feel the nodule here, at least you have thyroiditis. Go to the first floor to pay for it and check the thyroid function."

　　This is not the first time that Ms. Chen has paid for the blood test of "thyroid function" in the United States. Last November, in the same health store, B-ultrasound showed that she had "thyroid nodules". To this end, she paid about 200 yuan’s thyroid function examination fee after the discount.

　　"Every time I say that there is a problem with the thyroid gland, check the function. If the blood is fine, it doesn’t matter." Two blood test reports of Ms. Chen showed that her thyroid function was normal.

　　This year, because of the "diffuse echo" accompanied by thyroid nodules, Ms. Chen went to the endocrinology department of a well-known 3A hospital in Shanghai for re-examination after the physical examination that morning. After introducing her physical examination to the doctor, the doctor gave a diagnosis of "thyroiditis" and asked her to do another B-ultrasound and thyroid function examination in the hospital.

　　This time, the doctor who did the B-ultrasound told her, "Are you thyroiditis? Congratulations, you have recovered. " Ms. Chen once again asked if her thyroid nodules were still there. The doctor of B-ultrasound told her with great certainty: "From the imaging point of view, your thyroid gland is all normal, without nodules and inflammation."

　　The blood test report is also the same result, and everything is normal. "I can’t believe that the surgical experts in the physical examination center in the morning can even find out that I have a big nodule; In the afternoon, the B-ultrasound of the regular hospital showed no nodules. " It is worth noting that when Ms. Chen told her family about her experience, her father, mother, father-in-law and mother-in-law all replied that they had also encountered the above situation. Four elderly people have never had thyroid diseases, and all the medical examination packages use the 1056-yuan beauty health package purchased online by Ms. Chen, and all of them pay for the thyroid function on the spot during the medical examination.

　　A few days ago, the reporter visited the Mei Nianda Health Check-up Center in Shanghai Pudong Changhang Hospital mentioned by Ms. Chen, and saw a long queue for paying fees on the first floor. All the people in the queue buy temporary physical examination items after purchasing the physical examination package, and six of the nine people pay for thyroid function examination.

　　A similar situation occurred in many medical institutions.

　　Coincidentally, the same problem happened to Ms. Lin and her colleagues in Luoyang, Henan Province, and the thyroid function test was the one that broke the problem.

　　"You have a big problem, diffuse thyroid disease." Ms. Lin still remembers the diagnosis given by the B-ultrasound "doctor" on the spot when she was examined at the Mei Nianda Health Physical Examination Center in Luoyang. The situation she encountered was almost exactly the same as that of Ms. Chen in Shanghai. The "doctor" reminded her, "You just took blood, so go and pay the money. You don’t need to take any more blood. Have a test."

　　"At the payment office, I met five or six colleagues who came to add money to do thyroid function (examination). It didn’t feel right." After consulting her brother who works in the county people’s hospital, Ms. Lin gave up the payment and went to the county hospital for re-examination the next day. The hospital B-ultrasound and blood test report showed that Ms. Lin’s thyroid gland was all normal.

　　According to "China Consumer News", in June this year, Ms. Shi, a citizen of Nanjing, found that "the right thyroid nodule is accompanied by calcification, and there is a hypoechoic nodule in the right thyroid lobe, the size is about 10mm×8mm". But later, when Ms. Shi was reexamined in jiangsu province hospital, the B-ultrasound showed that "bilateral thyroid glands were normal in shape, with clear boundaries, smooth surface and normal internal blood flow, and no obvious abnormal lymph images were found in bilateral necks".

　　In response to this problem, the medical examination institution in Nanjing replied that "the doctor was sick and paralyzed and returned to his hometown". In response to the error in the medical report, the person in charge said that "it may be caused by many factors such as doctor technology and medical equipment problems".

　　The reporter noted that the chaos in the medical examination market has already become the focus of public opinion. Previously, the "Analysis Report on the Development Prospects and Investment Forecast of Health Examination Industry" released by Forward-looking Industry Research Institute showed that the health examination industry in China grew to 94 billion yuan with a growth rate of more than 25% in 2015, which was more than twice the growth rate of 29.5 billion yuan in 2010. The compound growth rate of the industry in the five years from 2011 to 2015 reached 21%, which was higher than that of the entire medical service industry. It is estimated that the scale of the health examination market in China will reach in 2018.

　　Do medical institutions earn money by adding items?

　　"Some institutions rely on capital to promote physical examination business. It sells physical examination as a product, collects money by project, and gives commissions according to the total amount of fees." The relevant person in charge of the physical examination center of a public hospital in Shanghai told the reporter that taking the physical examination project of middle-aged and elderly people as an example, the products purchased by private institutions at a price around 1000 yuan may cost 1,200 yuan to 1,300 yuan in public hospitals. "It can’t lose money, so he wants you to add projects, and it is most appropriate to make efforts on the A-level and liver-level."

　　According to the person in charge, thyroid diseases mostly occur in women aged 30-50, and the incidence of liver diseases is higher in men, and both diseases have the characteristics of "B-ultrasound+blood test". "The package of medical institutions generally only contains B-ultrasound examination, and blood test items are purchased on site."

　　The reporter interviewed the relevant person in charge of the Health Marketing Department of Mei Nianda. The person in charge responded that the agency has a strict review system for the customer’s physical examination report, and customers can consult and answer questions by telephone or online according to the process. In response to the question of "adding thyroid function", the person in charge said, "From the perspective of disease screening, thyroid ultrasound and thyroid function are indeed more suitable for combined detection and cannot replace each other."

　　"Thyroid function should be a must-check item, and it is not necessary to have surgery or B-ultrasound abnormalities to do thyroid function (examination)." The person in charge said that the incidence of thyroid-related diseases is relatively high at present, so it is suggested that medical examination consumers list this as a "must-check item".

　　The reporter noted that in recent years, complaints and disputes against private medical institutions have continued. Some people took the medical examination institution to court because the medical examination failed to detect cancer, and some people claimed compensation from the medical examination institution through the Consumers Association because of the malicious addition of the medical examination. "Can’t find the problem, to complain; After finding out the problem, there is no problem after being examined by a regular hospital, and you have to complain. " The person in charge of the medical examination department of the above-mentioned public hospital told the reporter. With the improvement of people’s living standards, physical examination has become an important means of health management for many people to "check out their own pockets" every year. However, physical examination is not a formal treatment after all, and it can only play a role of prompting and reminding. "There will definitely be inaccurate situations, and eventually we will go to a regular hospital for review and follow-up."

　　The 2017 annual report released by Mei Nianda Health in the middle of this year shows that physical examination service is the main business of Mei Nianda Health. In 2017, this business achieved an operating income of 6.142 billion yuan, accounting for 98.54% of the total revenue and a gross profit margin of 46.61%.

　　China Youth Daily Zhongqing Online Reporter Wang Yejie

Catalogue

????Chapter I General Principles

????Chapter II Traditional Chinese Medicine Services

????Chapter III Protection and Development of Traditional Chinese Medicine

????Chapter IV Training of Traditional Chinese Medicine Talents

????Chapter V Scientific Research on Traditional Chinese Medicine

????Chapter VI Traditional Chinese Medicine Inheritance and Cultural Communication

????Chapter VII Safeguard Measures

????Chapter VIII Legal Liability

????Chapter IX Supplementary Provisions

Chapter I General Principles

????the first?This law is formulated in order to inherit and carry forward Chinese medicine, guarantee and promote the development of Chinese medicine and protect people’s health.

????the second?The term "traditional Chinese medicine" as mentioned in this Law refers to the medicines of all ethnic groups in China, including medicines of Han nationality and minority nationalities. It is a medical and pharmaceutical system that reflects the Chinese people’s understanding of life, health and diseases, and has a long history and tradition and unique theories and technical methods.

????Article Traditional Chinese medicine is an important part of China’s medical and health undertakings. The state vigorously develops the cause of Chinese medicine, implements the principle of paying equal attention to both Chinese and western medicine, establishes a management system that conforms to the characteristics of Chinese medicine, and gives full play to the role of Chinese medicine in China’s medical and health undertakings.

????The development of Chinese medicine should follow the development law of Chinese medicine, adhere to the combination of inheritance and innovation, maintain and give play to the characteristics and advantages of Chinese medicine, and use modern science and technology to promote the development of Chinese medicine theory and practice.

????The state encourages Chinese medicine and western medicine to learn from each other, complement each other, develop in a coordinated way, give play to their respective advantages, and promote the integration of Chinese and western medicine.

????Article 4 The people’s governments at or above the county level shall incorporate the cause of Chinese medicine into the national economic and social development plan, establish and improve the management system of Chinese medicine, and promote the development of Chinese medicine as a whole.

????Article 5 The competent department of traditional Chinese medicine in the State Council is responsible for the management of traditional Chinese medicine throughout the country. Other relevant departments in the State Council are responsible for the work related to the management of traditional Chinese medicine within their respective responsibilities.

????The competent departments of traditional Chinese medicine of local people’s governments at or above the county level shall be responsible for the administration of traditional Chinese medicine in their respective administrative areas. Other relevant departments of the local people’s governments at or above the county level shall be responsible for the work related to the administration of traditional Chinese medicine within their respective functions and duties.

????Article 6 The state strengthens the construction of Chinese medicine service system, rationally plans and allocates Chinese medicine service resources, and provides protection for citizens to obtain Chinese medicine services.

????The state supports social forces to invest in Chinese medicine, and supports organizations and individuals to donate and fund Chinese medicine.

????Article 7 The state develops Chinese medicine education, establishes a Chinese medicine education system with appropriate scale, reasonable structure and various forms to meet the needs of the development of Chinese medicine, and trains Chinese medicine talents.

????Article 8 The state supports scientific research and technological development of traditional Chinese medicine, encourages scientific and technological innovation of traditional Chinese medicine, promotes the application of scientific and technological achievements of traditional Chinese medicine, protects intellectual property rights of traditional Chinese medicine and improves the scientific and technological level of traditional Chinese medicine.

????Article 9 The state supports the foreign exchange and cooperation of traditional Chinese medicine and promotes the international spread and application of traditional Chinese medicine.

????Article 10 Organizations and individuals who have made outstanding contributions to the cause of Chinese medicine shall be commended and rewarded in accordance with the relevant provisions of the state.

Chapter II Traditional Chinese Medicine Services

????Article 11 The people’s governments at or above the county level shall incorporate the construction of medical institutions of traditional Chinese medicine into the planning for the establishment of medical institutions, hold medical institutions of traditional Chinese medicine with appropriate scale, and support the development of medical institutions with characteristics and advantages of traditional Chinese medicine.

????The opinions of the competent department of traditional Chinese medicine of the people’s government at the next higher level shall be sought for the merger, revocation or change of the nature of traditional Chinese medicine medical institutions organized by the government.

????Article 12 General hospitals, maternal and child health care institutions and qualified specialized hospitals, community health service centers and township hospitals organized by the government shall set up departments of traditional Chinese medicine.

????The people’s governments at or above the county level shall take measures to enhance the ability of community health service stations and village clinics to provide Chinese medicine services.

????Article 13 The state supports social forces to set up medical institutions of traditional Chinese medicine.

????Chinese medical institutions run by social forces enjoy the same rights as Chinese medical institutions run by the government in terms of access, practice, basic medical insurance, scientific research and teaching, and professional title evaluation of medical personnel.

????Article 14 The establishment of medical institutions of traditional Chinese medicine shall go through the examination and approval procedures in accordance with the relevant provisions of the state on the management of medical institutions, and abide by the relevant provisions on the management of medical institutions.

????If a Chinese medicine clinic is held, the name, address, scope of diagnosis and treatment and staffing of the clinic shall be reported to the competent department of Chinese medicine of the local people’s government at the county level for the record before practicing activities can be carried out. Chinese medicine clinics shall publicize the scope of diagnosis and treatment, the names of Chinese medicine practitioners and their scope of practice in the clinic, and shall not carry out medical activities beyond the scope of filing. The specific measures shall be formulated by the competent department of traditional Chinese medicine in the State Council, and submitted to the health administrative department of the State Council for examination and release.

????Article 15 Personnel engaged in medical activities of traditional Chinese medicine shall, in accordance with the provisions of the Law of People’s Republic of China (PRC) Municipality on Medical Practitioners, obtain the qualification of traditional Chinese medicine doctors through the qualification examination of traditional Chinese medicine doctors and register for practice. The content of the qualification examination for TCM doctors should reflect the characteristics of TCM.

????People who study Chinese medicine by way of apprenticeship or who have acquired expertise in medical skills after years of practice are recommended by at least two Chinese medicine doctors and qualified by the competent departments of Chinese medicine of the people’s governments of provinces, autonomous regions and municipalities directly under the Central Government to organize practical skills and effects assessment, and then they can obtain the qualification of Chinese medicine doctors; After practicing registration according to the assessment content, you can engage in medical activities of traditional Chinese medicine in the form of personal practice or in medical institutions within the registered scope of practice. The competent department of traditional Chinese medicine in the State Council shall, according to the safety risks of the technical methods of traditional Chinese medicine, formulate the classification assessment methods for the personnel specified in this paragraph, and report them to the health administrative department of the State Council for examination and release.

????Article 16 Medical institutions of traditional Chinese medicine should be equipped with medical personnel, mainly Chinese medicine professional and technical personnel, mainly providing Chinese medicine services; Traditional Chinese medicine doctors who have obtained the qualification of doctors through examination may adopt modern scientific and technological methods related to their majors in their practice activities after passing the training and examination in accordance with the relevant provisions of the state. The use of modern scientific and technological methods in medical activities should be conducive to maintaining and giving play to the characteristics and advantages of traditional Chinese medicine.

????Community health service centers, township hospitals, community health service stations and conditional village clinics should be reasonably equipped with professional and technical personnel of traditional Chinese medicine, and apply and popularize appropriate technical methods of traditional Chinese medicine.

????Article 17 To carry out Chinese medicine service, we should take the theory of Chinese medicine as the guide, use Chinese medicine technology and methods, and meet the basic requirements of Chinese medicine service formulated by the competent department of Chinese medicine in the State Council.

????Article 18 The people’s governments at or above the county level shall develop Chinese medicine prevention and health care services, and incorporate them into the basic public health service projects in accordance with relevant state regulations.

????The people’s governments at or above the county level shall play the role of traditional Chinese medicine in the emergency work of public health emergencies, and strengthen the reserve of emergency materials, equipment, facilities, technology and human resources of traditional Chinese medicine.

????Medical and health institutions should actively use the theory and technical methods of traditional Chinese medicine in disease prevention and control.

????Article 19 The publication of medical advertisements of traditional Chinese medicine by medical institutions shall be examined and approved by the competent departments of traditional Chinese medicine of the local people’s governments of provinces, autonomous regions and municipalities directly under the Central Government; Without examination and approval, it shall not be published. The contents of TCM medical advertisements published shall be consistent with the contents examined and approved, and comply with the relevant provisions of the Advertising Law of People’s Republic of China (PRC).

????Article 20 The competent department of traditional Chinese medicine of the people’s government at or above the county level shall strengthen the supervision and inspection of traditional Chinese medicine services, and take the following matters as the focus of supervision and inspection:

????(a) whether the medical institutions of traditional Chinese medicine and doctors of traditional Chinese medicine carry out medical activities beyond the prescribed scope;

????(two) whether the development of traditional Chinese medicine services meets the basic requirements of traditional Chinese medicine services formulated by the competent department of traditional Chinese medicine in the State Council;

????(3) Whether the publishing of medical advertisements of traditional Chinese medicine conforms to the provisions of this Law.

????The competent department of traditional Chinese medicine shall carry out supervision and inspection according to law, and the relevant units and individuals shall cooperate with it and shall not refuse or obstruct it.

Chapter III Protection and Development of Traditional Chinese Medicine

????Article 21 The state formulates technical specifications and standards for the cultivation, breeding, collection, storage and primary processing of Chinese herbal medicines, strengthens the quality supervision and management of the whole process of production and circulation of Chinese herbal medicines, and ensures the quality and safety of Chinese herbal medicines.

????Article 22 The state encourages the development of standardized cultivation and breeding of Chinese herbal medicines, strictly controls the use of agricultural inputs such as pesticides and fertilizers, prohibits the use of highly toxic and toxic pesticides in the process of planting Chinese herbal medicines, supports the breeding of fine varieties of Chinese herbal medicines, and improves the quality of Chinese herbal medicines.

????Article 23 The state establishes an evaluation system for authentic Chinese herbal medicines, supports the breeding of authentic Chinese herbal medicines, supports the construction of authentic Chinese herbal medicine production bases, strengthens the ecological environment protection of authentic Chinese herbal medicine production bases, and encourages the protection of geographical indications and other measures to protect authentic Chinese herbal medicines.

????Chinese herbal medicines mentioned in the preceding paragraph refer to Chinese herbal medicines that have been selected through long-term clinical application of Chinese medicine, produced in a specific region, and have better quality and curative effect, stable quality and high popularity compared with the same Chinese herbal medicines produced in other regions.

????Article 24 The drug supervision and administration department of the State Council shall organize and strengthen the monitoring of the quality of Chinese herbal medicines, and regularly publish the monitoring results to the public. The relevant departments of the State Council shall assist in the quality monitoring of Chinese herbal medicines.

????The collection, storage and preliminary processing of Chinese herbal medicines shall conform to the relevant technical specifications, standards and management regulations of the state.

????The state encourages the development of modern circulation system of Chinese herbal medicines, improves the technical level of packaging and storage of Chinese herbal medicines, and establishes a traceability system for the circulation of Chinese herbal medicines. Pharmaceutical production enterprises shall establish a system of inspection and record for purchasing Chinese herbal medicines. Operators of Chinese herbal medicines shall establish a system of purchasing inspection and purchase and sale records, and indicate the origin of Chinese herbal medicines.

????Article 25 The state protects medicinal wild animal and plant resources, implements dynamic monitoring and regular survey of medicinal wild animal and plant resources, establishes a germplasm gene bank of medicinal wild animal and plant resources, encourages the development of artificial planting and breeding, and supports the protection, breeding and related research of precious and endangered medicinal wild animals and plants according to law.

????Article 26 Traditional Chinese medicine practitioners practicing in village medical institutions and rural doctors with knowledge and recognition ability of Chinese herbal medicines may, in accordance with the relevant provisions of the state, grow and collect Chinese herbal medicines from their own land and use them in their practice activities.

????Article 27 The state protects the traditional processing technology and technology of Chinese herbal pieces, supports the application of traditional processing technology to Chinese herbal pieces, and encourages the use of modern science and technology to carry out research on processing technology of Chinese herbal pieces.

????Article 28 For Chinese herbal pieces that are not available in the market, medical institutions can process and use them in their own medical institutions according to the needs of doctors’ prescriptions. Medical institutions shall abide by the relevant provisions on the processing of Chinese herbal pieces, be responsible for the quality of Chinese herbal pieces processed by them, and ensure the safety of drugs. Medical institutions processing Chinese herbal pieces shall file with the pharmaceutical supervisory and administrative department of the municipal people’s government where the district is located.

????According to the needs of clinical medication, medical institutions can reprocess Chinese herbal pieces according to the prescriptions of their doctors.

????Article 29 The state encourages and supports the research and production of new Chinese medicine.

????The state protects the processing technology and technology of traditional Chinese medicine, supports the production of traditional Chinese patent medicines, and encourages the use of modern science and technology to research and develop traditional Chinese patent medicines.

????Article 30 When applying for the drug approval number, only non-clinical safety research data can be provided for the production of traditional Chinese medicine compound preparations that meet the requirements stipulated by the state and come from ancient classic prescriptions. The specific management measures shall be formulated by the drug supervision and administration department of the State Council in conjunction with the competent department of traditional Chinese medicine.

????The ancient classic prescriptions mentioned in the preceding paragraph refer to prescriptions recorded in ancient Chinese medical books and records that are still widely used, with definite curative effect and obvious characteristics and advantages. The specific catalogue shall be formulated by the competent department of traditional Chinese medicine of the State Council in conjunction with the drug supervision and administration department.

????Article 31 The state encourages medical institutions to prepare and use traditional Chinese medicine preparations according to their clinical medication needs, supports the preparation of traditional Chinese medicine preparations by traditional techniques, and supports the development of new Chinese medicine based on traditional Chinese medicine preparations.

????Medical institutions preparing traditional Chinese medicine preparations shall obtain preparation licenses for medical institutions in accordance with the provisions of the Drug Administration Law of People’s Republic of China (PRC), or entrust pharmaceutical production enterprises that have obtained drug production licenses or other medical institutions that have obtained preparation licenses for medical institutions to prepare traditional Chinese medicine preparations. Entrusted preparation of traditional Chinese medicine preparations shall be filed with the pharmaceutical supervisory and administrative department of the people’s government of the province, autonomous region or municipality directly under the Central Government where the entrusting party is located.

????Medical institutions are responsible for the quality of Chinese medicine preparations prepared by them; Where the traditional Chinese medicine preparation is entrusted, the entrusting party and the entrusted party shall bear corresponding responsibilities for the quality of the prepared traditional Chinese medicine preparation.

????Article 32 The varieties of traditional Chinese medicine preparations prepared by medical institutions shall obtain the preparation approval number according to law. However, only the varieties of traditional Chinese medicine preparations prepared by traditional techniques can be prepared after filing with the pharmaceutical supervisory and administrative department of the people’s government of the province, autonomous region or municipality directly under the Central Government where the medical institution is located, and there is no need to obtain the preparation approval number.

????Medical institutions should strengthen the monitoring of adverse reactions of the varieties of traditional Chinese medicine preparations for the record, and report them in accordance with the relevant provisions of the state. The pharmaceutical supervisory and administrative department shall strengthen the supervision and inspection of the preparation and use of the varieties of traditional Chinese medicine preparations for the record.

Chapter IV Training of Traditional Chinese Medicine Talents

????Article 33 Chinese medicine education should follow the growth law of Chinese medicine talents, give priority to the content of Chinese medicine, reflect the cultural characteristics of Chinese medicine, and pay attention to the combination of classical theory of Chinese medicine and clinical practice of Chinese medicine, modern education methods and traditional education methods.

????Article 34 The state improves the educational system of Chinese medicine schools and supports the development of institutions of higher learning, secondary vocational schools and other educational institutions specializing in Chinese medicine education.

????The training objectives, years of schooling, teaching forms, teaching contents, teaching evaluation and academic level evaluation standards of Chinese medicine school education should reflect the characteristics of Chinese medicine and conform to the law of the development of Chinese medicine.

????Article 35 The state develops the apprenticeship education of Chinese medicine, supports Chinese medicine doctors and Chinese medicine professionals with rich clinical experience and technical expertise to teach students in their practice and business activities, teaches Chinese medicine theories and technical methods, and trains Chinese medicine professionals and technicians.

????Article 36 The state strengthens the cultivation and training of Chinese medicine doctors and professional and technical personnel of Chinese medicine at the grassroots level in urban and rural areas.

????The state develops the education of integrated traditional Chinese and western medicine and trains high-level talents of integrated traditional Chinese and western medicine.

????Article 37 The competent department of traditional Chinese medicine of the local people’s government at or above the county level shall organize the continuing education of traditional Chinese medicine and strengthen the training of basic knowledge and skills of traditional Chinese medicine for medical personnel, especially urban and rural grassroots medical personnel.

????Professional and technical personnel of traditional Chinese medicine should participate in continuing education in accordance with the regulations, and their institutions should create conditions for them to receive continuing education.

Chapter V Scientific Research on Traditional Chinese Medicine

????Article 38 The state encourages scientific research institutions, institutions of higher learning, medical institutions and pharmaceutical production enterprises to apply modern science and technology and traditional Chinese medicine research methods to carry out scientific research on Chinese medicine, strengthen the research on the integration of Chinese and Western medicine, and promote the inheritance and innovation of Chinese medicine theory and technical methods.

????Article 39 The state takes measures to support the collation, research and utilization of ancient Chinese medicine documents, academic ideas and diagnosis and treatment experience of famous Chinese medicine experts and folk Chinese medicine techniques and methods.

????The state encourages organizations and individuals to donate Chinese medicine literature, secret recipes, prescriptions, diagnosis and treatment methods and technologies with scientific research and clinical application value.

????Article 40 The state establishes and improves the scientific and technological innovation system, evaluation system and management system that conform to the characteristics of traditional Chinese medicine, and promotes the scientific and technological progress and innovation of traditional Chinese medicine.

????Article 41 The state takes measures to strengthen scientific research on the basic theories and methods of syndrome differentiation and treatment of traditional Chinese medicine, the prevention and treatment of common diseases, frequently-occurring diseases, chronic diseases, major difficult diseases and major infectious diseases, and other projects that have a significant role in promoting the development of theory and practice of traditional Chinese medicine.

Chapter VI Traditional Chinese Medicine Inheritance and Cultural Communication

????Article 42 For the theories and technical methods of traditional Chinese medicine with important academic value, the competent department of traditional Chinese medicine of the people’s government at or above the provincial level shall organize the selection of academic inheritance projects and inheritors of traditional Chinese medicine within their respective administrative areas, and provide necessary conditions for inheritance activities. Inheritors should carry out inheritance activities, cultivate successors, collect and properly preserve relevant academic materials. Belong to the intangible cultural heritage representative projects, in accordance with the relevant provisions of the "People’s Republic of China (PRC) Intangible Cultural Heritage Law" to carry out inheritance activities.

????Article 43 The state establishes a database, a list and a system for the protection of traditional Chinese medicine knowledge.

????Holders of traditional Chinese medicine knowledge have the right to inherit and use their traditional Chinese medicine knowledge, and enjoy the rights of informed consent and benefit sharing for others to obtain and use their traditional Chinese medicine knowledge.

????The state protects the prescription composition and production technology of traditional Chinese medicines that are legally recognized as state secrets.

????Article 44 The state develops TCM health care services and supports social forces to set up standardized TCM health care institutions. TCM health care service norms and standards shall be formulated by the competent department of traditional Chinese medicine in the State Council.

????Article 45 The people’s governments at or above the county level shall strengthen the propaganda of Chinese medicine culture, popularize the knowledge of Chinese medicine, and encourage organizations and individuals to create Chinese medicine culture and popular science works.

????Article 46 To carry out cultural propaganda and knowledge popularization activities of traditional Chinese medicine, the relevant provisions of the state shall be observed. No organization or individual may make false or exaggerated propaganda on traditional Chinese medicine, or seek illegitimate interests in the name of traditional Chinese medicine.

????Radio, television, newspapers, the Internet and other media to carry out traditional Chinese medicine knowledge propaganda, should hire professional and technical personnel of traditional Chinese medicine.

Chapter VII Safeguard Measures

????Article 47 The people’s governments at or above the county level shall provide policy support and conditions for the development of Chinese medicine, and incorporate the development funds of Chinese medicine into the fiscal budget at the corresponding level.

????The people’s governments at or above the county level and their relevant departments shall formulate basic medical insurance payment policies, drug policies and other medical and health policies, with the participation of the competent departments of traditional Chinese medicine, pay attention to the advantages of traditional Chinese medicine, and support the provision and utilization of traditional Chinese medicine services.

????Article 48 The people’s governments at or above the county level and their relevant departments shall, in accordance with the statutory price management authority, reasonably determine the charging items and standards of Chinese medical services, reflecting the cost and professional and technical value of Chinese medical services.

????Article 49 The relevant departments of the local people’s governments at or above the county level shall, in accordance with the provisions of the state, include qualified medical institutions of traditional Chinese medicine into the scope of designated medical institutions of basic medical insurance, and include qualified TCM diagnosis and treatment items, Chinese herbal pieces, Chinese patent medicines and Chinese medicinal preparations of medical institutions into the scope of payment of the basic medical insurance fund.

????Article 50 The state strengthens the construction of the standard system of traditional Chinese medicine, formulates standards and revises them in time according to the technical requirements that need to be unified according to the characteristics of traditional Chinese medicine.

????The national standards and industry standards of traditional Chinese medicine shall be formulated or revised by the relevant departments of the State Council according to their responsibilities, and published on their websites for free access by the public.

????The state promotes the establishment of an international standard system for traditional Chinese medicine.

????Article 51 To carry out the evaluation, evaluation and appraisal activities related to traditional Chinese medicine as stipulated by laws and administrative regulations, a special organization for evaluation, evaluation and appraisal of traditional Chinese medicine shall be established, or Chinese medicine experts shall participate.

????Article 52 The state takes measures to increase the support for the inheritance, innovation, application and development of minority medicine and personnel training, strengthen the construction of minority medical institutions and doctors, and promote and standardize the development of minority medicine.

Chapter VIII Legal Liability

????Article 53 Where the competent department of traditional Chinese medicine of the people’s government at or above the county level and other relevant departments fail to perform their duties as stipulated in this Law, the people’s government at the corresponding level or the relevant department of the people’s government at a higher level shall order them to make corrections; If the circumstances are serious, the directly responsible person in charge and other directly responsible personnel shall be punished according to law.

????Article 54 In violation of the provisions of this law, Chinese medicine clinics carry out medical activities beyond the scope of filing, and the competent department of Chinese medicine of the local people’s government at the county level shall order it to make corrections, confiscate its illegal income and impose a fine of not less than 10,000 yuan but not more than 30,000 yuan; If the circumstances are serious, it shall be ordered to stop practicing activities.

????Where a Chinese medicine clinic is ordered to stop practicing, the directly responsible person in charge shall not engage in management within five years from the date of making the punishment decision. If a medical institution employs the above-mentioned personnel who are not allowed to engage in management work, the original license issuing department shall revoke the practice license or the original filing department shall order it to stop practicing activities.

????Article 55 In violation of the provisions of this law, Chinese medicine practitioners who have obtained the qualification of doctors after examination are engaged in medical activities beyond the registered scope of practice, and the competent department of traditional Chinese medicine of the people’s government at or above the county level shall order them to suspend their practice activities for more than six months and less than one year, and impose a fine of more than 10,000 yuan and less than 30,000 yuan; If the circumstances are serious, the practicing certificate shall be revoked.

????Article 56 In violation of the provisions of this law, the establishment of Chinese medicine clinics, the processing of Chinese herbal pieces, and the entrusted preparation of Chinese medicine preparations should be filed but not filed, or false materials are provided at the time of filing, and the competent department of Chinese medicine and the pharmaceutical supervisory and administrative department shall, according to their respective functions and duties, order them to make corrections, confiscate their illegal income, impose a fine of not more than 30,000 yuan, and announce relevant information to the public; Refuses to correct, shall be ordered to stop practicing activities or ordered to stop processing traditional Chinese medicine pieces, commissioned the preparation of traditional Chinese medicine preparation activities, the directly responsible personnel shall not engage in traditional Chinese medicine related activities within five years.

????Medical institutions that use traditional techniques to prepare traditional Chinese medicine preparations are not filed in accordance with the provisions of this law, or fail to prepare traditional Chinese medicine preparations in accordance with the requirements specified in the filing materials, and will be punished according to the production of counterfeit drugs.

????Article 57 In violation of the provisions of this law, if the contents of the published Chinese medicine medical advertisements are inconsistent with the contents examined and approved, the original examination department shall revoke the examination and approval documents of the advertisements, and shall not accept the advertisement examination application of the medical institution within one year.

????In violation of the provisions of this law, publishing medical advertisements of traditional Chinese medicine has illegal acts other than those specified in the preceding paragraph, and shall be punished in accordance with the provisions of the Advertising Law of People’s Republic of China (PRC).

????Article 58 Anyone who, in violation of the provisions of this Law, uses highly toxic or toxic pesticides in the process of planting Chinese herbal medicines shall be punished in accordance with the provisions of relevant laws and regulations; If the circumstances are serious, the public security organ may detain the directly responsible person in charge and other directly responsible personnel for more than five days and less than fifteen days.

????Article 59 Anyone who violates the provisions of this law and causes personal or property damage shall bear civil liability according to law; If a crime is constituted, criminal responsibility shall be investigated according to law.

Chapter IX Supplementary Provisions

????Article 60 The management of traditional Chinese medicine, which is not provided for in this Law, shall be governed by the provisions of the Law of People’s Republic of China (PRC) on Medical Practitioners, the Drug Administration Law of People’s Republic of China (PRC) and other relevant laws and administrative regulations.

????The administration of traditional Chinese medicine in the army shall be organized and implemented by the competent department of health in the army in accordance with this law and the relevant provisions of the army.

????Article 61 Ethnic autonomous areas may, in accordance with the Law of People’s Republic of China (PRC) on Regional Ethnic Autonomy and the relevant provisions of this Law, formulate measures to promote and standardize the development of local ethnic medicine in light of the actual situation.

????Article 62 Blind people who have obtained the qualification of blind medical massage personnel in accordance with the relevant provisions of the state may provide medical massage services in the form of personal practice or in medical institutions.

????Article 63 This law shall come into force as of July 1, 2017.

　　　　　　 CCTV News:Not long ago, the local people in Hongdong County, Shanxi Province reported that there was a listed company named Sanwei Group in Hongdong County, which had been illegally dumping industrial waste residue, polluting farmland, and the wastewater from production was directly discharged into Fenhe River, posing a threat to the lives of people in villages along the way. CCTV reporters went to Hongtong County to investigate.

　　　　　　 Shanxi Sanwei Group is a large state-owned chemical enterprise and a listed company. It was once rated as one of the 36 advantageous enterprises in Shanxi Province. As soon as I arrived here, the reporter found a strange phenomenon. Among the trucks that normally transport goods, there were some vehicles covered with dirt. The reporter followed the empty car into the factory. More than 200 meters away from the gate, the reporter saw trucks lined up, waiting to be loaded under a huge device. What they loaded was a dark gray industrial waste residue with a pungent smell.

　　　　　　 After passing through several villages, about 2 kilometers away from the three-dimensional group factory, the big truck drove into a yard. Go straight to the deepest part of the yard. A whole vehicle of white industrial waste residue was dumped in a huge pit, and gray and white industrial waste residue rolled down to the bottom of the pit along the position where the truck stopped. This is a huge pit, there are two football fields with a large area, and the height difference is about 30 meters. The industrial waste residue that has just been dumped has a stronger and more pungent taste here.

　　　　　　 According to the public information on the Internet, Sanwei Group is an enterprise that produces hundreds of chemical products such as polyvinyl alcohol, adhesives, benzene and coke. The gray-black powder being dumped is fly ash, while the gray-white thing is carbide slag.

　　　　　　 China’s Law on the Prevention and Control of Environmental Pollution by Solid Waste clearly stipulates that solid waste shall not be dumped or piled up without authorization, and measures shall be taken to prevent or reduce the environmental pollution caused by solid waste. So, has this three-dimensional group in Hongtong County taken measures as stipulated by law? What impact will such dumping have on the local environment?

　　　　　　 Article 16 of China’s Law on the Prevention and Control of Environmental Pollution by Solid Waste stipulates that units and individuals that produce solid waste shall take measures to prevent or reduce environmental pollution by solid waste; Article 17 stipulates that units and individuals that collect, store, transport, utilize and dispose of solid waste must take measures to prevent scattering, loss, leakage or other environmental pollution; Do not dump, pile up, discard or scatter solid waste without authorization.

　　　　　　 Calcium carbide slag and fly ash belong to the category of industrial solid waste, which will not only drift with the wind, but also affect the air. Once washed by rain, they will easily penetrate underground, causing secondary pollution to groundwater and soil. At the same time, carbide slag is a strong alkaline substance, which has stimulating and corrosive effects. Inhalation of dust has strong irritation to human respiratory tract and eyes, and may even cause pneumonia and burns. These two kinds of industrial solid wastes need to be stored in a special storage yard and managed strictly.

　　　　　　 However, the reporter’s investigation found that there was no corresponding impervious layer at the bottom of this pit. Industrial waste residue was dumped in a big pit, and then "disguised" into a new slag yard, and the industrial waste residue buried underground became an unknown "secret". On the other side of this pit, the distance less than 100 meters is Xinzhuang Village, Zhaocheng Town, Hongtong County. According to the villagers in Xinzhuang village, this pit was dug a few years ago, and the largest amount was dug last year.

　　　　　　 Xinzhuang Village, Zhaocheng Town, Hongdong County, has a land area of less than one mu per capita, and farmland is scattered on the loess high slope with ravines. It is the season of wheat growth, but the reporter saw that only a few centimeters high buds just broke through the ground, but they were covered with a layer of black powder.

　　　　　　 【 Consequence 】 Farmland polluted crops can’t live

　　　　　　 Today, with the country’s efforts to improve environmental protection and create green mountains and green rivers, a listed company has been so unscrupulous in stealing and dumping industrial waste, and the number is amazing. With the deepening of the investigation, the reporter found that the pollution of the three-dimensional group is far more than dumping industrial waste at will.

　　　　　　 This is Xigou Village, Zhaocheng Town, Hongtong County. The villagers told reporters that they were almost overwhelmed by pollution and the natural environment was seriously damaged. The reporter photographed a group of pictures in the air with an aerial camera. On the picture, this gully from east to west has no original color, and it has been replaced by gray waste residue all over the mountains.

　　　　　　 According to the villagers’ memories, although the land here is not fertile, most crops are growing well, but now they are surprised to find that many crops that could have been planted alive can no longer live.

　　　　　　 The villagers told reporters that the pollution of the three-dimensional group not only appeared in the dumping of industrial waste residue, but also the random discharge of industrial wastewater from this enterprise without treatment was even more shocking. Under the guidance of a villager, the reporter came to the bank of Fenhe River, and finally found a hidden sewage outlet after several turns. As soon as I arrived here, the reporter saw that the thick white industrial wastewater flowed out of the pipeline continuously, and with the pungent smell, the sewage changed color from time to time. White is pungent, while black is full of stench.

　　　　　　 The sewage outlet is buried underground. Why are the villagers so sure that the sewage is discharged by the three-dimensional group? It turned out that just a few years ago, the sewage pipes buried in the ground by enterprises were old and damaged, and industrial wastewater directly spilled into the villagers’ farmland, causing the crops in the field to die and the farmland could no longer be cultivated. After the incident, 3D Group also organized personnel to repair the pipeline.

　　　　　　 [accomplice] Village cadres blocked reporters’ investigation

　　　　　　 Just as the reporter was preparing for an in-depth investigation, several people who claimed to be village cadres in Guli stopped the reporter’s way. Two village cadres in Gouli village mistakenly thought that the reporter was a staff member of the Ministry of Environmental Protection, but they did not converge. When the reporter mentioned that there was sewage discharge by the Fenhe River, two village cadres wanted to hold the reporter hostage.

　　　　　　 Under the stalemate, the reporter had to call the police for help, and under the escort of the police, the reporter was finally able to leave. During the investigation, many villagers in Zhaocheng Town, Hongdong County told reporters that the reason why Sanwei Group dared to destroy the crops and dump the industrial waste directly in the village was because the village cadres and Sanwei Group negotiated privately and dumped these industrial waste in the village by way of contracting to seek benefits, while the opposing villagers were warned lightly and suffered from sticks, and the villagers could only swallow their voices.

　　　　　　 [Supervision] The local environmental protection bureau does not act as a laissez-faire enterprise to discharge pollutants

　　　　　　 In 2017, the Ministry of Environmental Protection sent eight inspection teams to inspect 13 cities, among which Sanwei Group was one of the inspected objects. However, after the inspection, the pollution of Sanwei Group not only did not stop, but became more and more rampant. So what is the attitude of the local environmental protection department towards such illegal enterprises?

Deputy Director of Hongtong County Environmental Protection Bureau

　　　　　　 On March 19th, the reporter came to the Environmental Protection Bureau of Hongtong County, Shanxi Province, and reported on the scene that 3D Group dumped industrial waste residue and directly discharged untreated industrial wastewater into Fenhe River. When the reporter asked if there was a storage site for industrial solid waste in Xinzhuang village, the staff member was always vague and said it was not clear. In order to find out the facts, the reporter then went to the office of the deputy director of the Environmental Protection Bureau of Hongtong County. The deputy director of Hongdong County Environmental Protection Bureau said that he was very clear about the dumping of industrial waste residue into the village by Sanwei Group. Because the village Committee cadres took the money and had an agreement, Hongdong County Environmental Protection Bureau should not intervene.

　　　　　　 [Progress] The detention of two village cadres is under investigation.

　　　　　　 Listed companies illegally discharge pollutants, village cadres pay money to guard the hospital, and local environmental protection departments ignore corporate violations. This scene in Hongtong County has reached an absurd level. With the increasingly serious pollution, it is the surrounding villagers who suffer.

　　　　　　 Last night, after the CCTV report was broadcast, Shanxi Provincial Environmental Protection Department rushed to the scene to conduct on-the-spot investigation, and Linfen City set up a criminal investigation task force. At present, two village cadres have been administratively detained for 15 days according to law. The other six parties involved in the report are being verified, and other relevant information is being further investigated.

　　　　　　 [Comment] Only by destroying the umbrella can we return the green mountains and green rivers to the people.

　　　　　　 On February 5th this year, the general offices of the General Office of the Central Committee of the CPC and the State Council issued the Three-year Action Plan for Renovating Rural Human Settlements, which clearly emphasized that improving rural human settlements is related to building a well-off society in an all-round way, the fundamental well-being of farmers and the civilization and harmony of rural society.

　　　　　　 A harmonious and beautiful new countryside cannot be realized in Gouli Village without investigating polluting enterprises, destroying umbrellas and dealing with unqualified cadres. We hope that the local government can implement the policies of the central government, implement the laws of the country, perform its duties and give the people a satisfactory answer.

Roewe, which has long insisted on driving the core market with core technology, took Roewe D7 as the first model of the new product series "D family" of SAIC Roewe, launched an offensive to the new energy car market, and set off a new round of competition oriented by "technical warfare" in the industry. Recently, Roewe D7 DMH completed the real endurance challenge of 1704km with only one tank of oil, which set a new record for the real endurance challenge of a fully charged car with one tank of oil in China. At the same time, the average fuel consumption per 100 kilometers was only 3.4L, showing the real hybrid strength of China cars.

Roewe meets the price war, and new and old users share the discount.

Near the end of the year, in the face of the market change of "exchanging price for quantity" launched by peer brands, Roewe bravely challenged and launched the year-end limited-time special offer: from now on, the limited-time price of Roewe D7 will be 109,800, and there will be a three-year 80,000-interest loan financial policy. With a down payment of 17,000, the car can be driven home, helping users to start a better car life on the eve of the new year. It is worth mentioning that Roewe has always insisted on safeguarding the interests of users, and promised to "share with old users", and Huili sincerely extended it directly. Roewe’s limited-time discount this time dared to take the initiative in the price war market, and ensured the rights and interests of users to the maximum extent through the policy of sharing new and old users, and sincerely gave back the support and love of old car owners with practical actions.　

As a solid fan of independent brands, Roewe is duty-bound to expand the market together with other China brands and participate in reshaping the value system. After Roewe D7 went public, plug-in hybrid and pure electric power versions were listed at the rights and interests prices of 121,800-141,800 and 143,800-170,800 respectively. On this basis, the official limited-time special offer further consolidated the price competitiveness of Roewe D7, and with a limited-time price of 109,800, the first shot of gratitude to consumers was launched in the peak season of car purchase at the end of the year, which penetrated the sincere reserve price of B-class cars.

Roewe DMH hybrid technology uses hard core technology to fight a protracted war

The reason why we dare to face the market challenges is because Roewe D7 has super core technology as the basis for facing the challenges. Roewe D7 has the blessing of SAIC’s new energy technology base and the empowerment of brand differentiation technology achievements, and its technology is far ahead; As the "100,000-class battery life is the strongest super-mixing", it brings consumers a comfortable, reliable and value-added new experience, and the products are far ahead; The listed rights and interests are superimposed on the year-end limited-time preferential treatment, and it is promised that "old users will share", and the rights and interests are far ahead. The three leading positions will help Roewe D7 break through quickly in the market and stabilize the new explosion of new energy cars.

In addition, Roewe D7 has promoted the new revolution of plug-in hybrid technology in China with its super hybrid hard power. Recently, in the "China Heart" 2023 Top Ten Engine and Hybrid System Selection Campaign, Roewe D7 DMH stood out from 15 automotive power systems such as Changan Ford, BMW Brilliance and FAW Hongqi in the dynamic testing link with excellent technical strength and excellent performance, and won the honor of "Top Ten Engine and Hybrid System", which is enough to show that the DMH super hybrid system, after the iteration of previous generations of hybrid systems of SAIC Roewe, "shine on you is better than Blue".

Based on technology and speaking with strength, Roewe D7 has truly achieved the experience of B-class cars, the quality of B-class cars and the price of A-class cars, and reshaped the new pattern of the middle and high-end new energy car market. For consumers with money to buy, the year-end limited-time discount launched this time is undoubtedly the best time for consumers to start the new explosion of Roewe D7 for new energy cars.

Source: Correspondent Feng Wei

Editor: Gao Zhengyang

Proofreading: Xiong Xiangning

Audit: Cang Shujun

　　People’s Daily Online, Wuhan, September 13 (Yan Jiaqi) On September 12, the second China Commercial Aerospace Summit Forum was held in Wuhan. At the opening ceremony of the forum, the signing ceremony of China’s first national commercial aerospace industry base settled in Wuhan was held. China Aerospace Science and Industry Corporation has released five major commercial aerospace projects, with an estimated investment of over 100 billion yuan and an output of over 100 billion yuan.

　　The forum was jointly sponsored by Wuhan Municipal People’s Government, China Aerospace Science and Industry Corporation, China Aerospace Science and Technology Corporation, China Electronics Technology Corporation, China Aerospace Foundation and China Aerospace Society, and was hosted by Beijing Aerospace Information and Information Research Institute. The theme was "Give play to agglomeration effect, help industrial development, and jointly build a new commercial aerospace format". More than 200 units, more than 700 leaders and experts from relevant ministries and commissions, military forces, local governments, enterprises, research institutes and universities gathered together to share technological innovation and application practices, promote the innovation and integration of business models, reach a consensus on the development strategy of industry sectors, and build a new format for commercial aerospace development.

　　At the opening meeting of the forum, China Aerospace Science and Industry Corporation held a signing ceremony with Hubei Provincial People’s Government and Wuhan Municipal People’s Government on the Special Cooperation Agreement on Promoting the Work of Wuhan National Aerospace Industry Base. The base is the first national commercial aerospace industrial base in China. On August 5, 2016, the Implementation Plan of Wuhan National Aerospace Industrial Base was officially approved by the National Development and Reform Commission. With the development of commercial space as the leading factor and the new generation of space launch and application as the core, the base will build four leading industries, including space launch vehicle and launch service, satellite platform and load, space information application service, space ground equipment and manufacturing, through scientific and technological innovation, business model innovation and management innovation. It is estimated that by 2020, Wuhan National Aerospace Industry Base will build an annual production capacity of 50 launch vehicles and 40 commercial satellites with an annual output of more than 100 kg and 100 commercial satellites with an annual output value of 30 billion yuan.

　　Gao Hongwei, chairman of China Aerospace Science and Industry Corporation, pointed out in his speech at the conference that aerospace science and industry will continue to promote the implementation of the following five major commercial aerospace projects mainly based on Wuhan National Aerospace Industry Base: Feiyun Project, corresponding to unmanned airborne regional network and its application projects; Fast cloud project, corresponding to the airship-borne LAN in the near space and its application project; Cloud project, corresponding to satellite-borne narrowband global mobile internet of things and its application projects; Hongyun project, corresponding to satellite-borne broadband global mobile internet and its application project; Tengyun project, corresponding to space shuttle aircraft and its application project. The development and construction of these five commercial aerospace industry projects will span more than ten years, involving thousands of sub-projects and sub-systems. It is estimated that the investment will exceed 100 billion and the output will exceed 100 billion.

　　In recent years, the foreign commercial aerospace industry has developed rapidly, and a number of innovative commercial aerospace companies have emerged. A series of practical projects with leading technology and innovative business models have attracted wide attention from the society. For example, SpaceX’s Falcon -9 completed the world’s first marine recovery rocket; Orbital ATK’s "Cygnus" cargo spacecraft sent the first commercial 3D printer to the International Space Station.

　　According to the "Aerospace Report" released by the American Aerospace Foundation in June 2016, in 2015, the total global aerospace economy reached 335.3 billion US dollars, of which 7.6 billion US dollars came from commercial space activities stations, totaling 246 billion US dollars, and commercial space has entered a mature stage.

　　Experts attending the meeting pointed out that in recent years, the Chinese government has attached great importance to actively developing the aerospace industry. With the gradual maturity of China’s spacecraft manufacturing industry and the gradual increase in the number of satellites, aerospace applications are in a stage of rapid development. China’s commercial space flight also ushered in a period of strategic opportunities, with huge development space.

1905 movie network news On November 30th, Professor of Performance Department of Beijing Film Academy and national first-class actor passed away at the age of 86. His representative works include Romance of the Three Kingdoms and so on.

Ma Jingwu was born in Urumqi, Xinjiang Uygur Autonomous Region in 1938.

When he was in high school in Urumqi, the People’s Daily published the enrollment information of the Film Academy. At that time, teachers and classmates jumped up and let him take the exam, and Ma Jingwu was moved. It was really hard to walk from Urumqi to Beijing for 19 days, but I was finally admitted. Ma Jingwu recalled in an interview with the film channel My Movie Story.

After graduating from Beijing Film Academy, Ma Jingwu stayed on as a teacher with excellent results. During his decades of teaching career, he has trained a large number of outstanding actors, such as,,, and so on.

His wife, who is also a teacher of Nortel, Ma Jingwu taught in the Performance Department of Nortel 87. At that time, she invited more than 20 students in her class to go home and cook for them personally. "So when we meet again after graduation, we are all like relatives. You love them and they naturally love you.".

In addition, Ma Jingwu not only directed films, but also played a major role in many feature films, such as Hanging the Red Lantern, and made many contributions to the film and television industry in China!

The Sri Lankan has passed away. May Ma Lao go all the way!

　　Beijing, May 9 (Reporter Zhang Ni) Recently, the nine-valent cervical cancer vaccine (HPV vaccine) was approved for listing in China, bringing good news to many women. HPV vaccine is the first vaccine in the world to include cancer as an indication. However, for many domestic people, this vaccine is still new, and the popularity of related knowledge is still limited.

　　How to vaccinate? How to choose the vaccine type that suits you? What preparations need to be made before vaccination? A few days ago, the reporter from Zhongxin. com interviewed Zhao Yun, deputy chief physician of gynecology department of Peking University People’s Hospital, on a series of issues of public concern.

　　— — What is the relationship between HPV virus and cervical cancer?

　　HPV is the abbreviation of the English name of "human papillomavirus". There are many members in the HPV family, and a few of them are closely related to malignant tumors, so they are called high-risk HPV. From the statistics of large population samples, 99% of cervical cancer is caused by infection with this kind of virus.

　　The main route of transmission of HPV virus is through sexual contact, and mucosal contact can also be transmitted.

　　When there is no sexual exposure, the probability of this virus infection is almost zero, but the probability of HPV infection in women who have sex is very high. About 70% to 80% of women may have been infected with this virus, especially when they are sexually active (usually before the age of 30), which is the peak of infection.

　　However, many infections are transient infections. With the increase of age, these viruses will be cleared away, and only a small number (10-15%) are in a state of persistent infection, which is the high-risk group of cervical precancerous lesions and cervical cancer.

　　— — What is the difference between bivalent, tetravalent and nonavalent vaccines?

　　At present, there are three kinds of HPV vaccines listed in the world: bivalent, tetravalent and nonavalent.

　　A bivalent vaccine can prevent infections caused by HPV16 and HPV18 viruses. International research data show that more than 70% of cervical cancer is caused by these two viruses.

　　The tetravalent vaccine can prevent the infection of HPV6, 11, 16 and 18 viruses. Although HPV6 and HPV11 are not high-risk HPV viruses of cervical cancer, they can cause condyloma of lower genital tract.

　　Nine-valent vaccine is aimed at nine subtypes of HPV6, 11, 16, 18, 31, 33, 45, 52 and 58. Studies show that nine-valent vaccine can prevent 90% of cervical cancer.

　　It should be pointed out that HPV vaccine can not prevent cervical cancer 100%, even after vaccination, cervical cancer screening should be carried out regularly.

　　— — What is the difference between the three vaccination ages?

　　In terms of vaccination age, the approved vaccination age in China is: bivalent vaccine is suitable for women aged 9-25, tetravalent vaccine is suitable for women aged 20-45, and ninevalent vaccine is suitable for women aged 16-26.

　　The division of age groups is determined based on the results of clinical experiments of different age groups in China. HPV vaccine is a preventive vaccine. At present, no results show that it has the effect of preventing diseases for people who have been infected with HPV virus contained in the vaccine. Therefore, population vaccination before sexual exposure has the best health economic effect.

　　In the position paper updated by WHO in May 2017, it is suggested that women aged 9-14 who have not had sex should be the main target population, and women over the age of 15 should be the secondary target population.

　　— — Is the applicable age of nine-valent vaccine in Hong Kong 9-45 years old?

　　The instructions for the nine-valent vaccine in Hong Kong are applicable to 9-45 years old. However, there is no clinical data on the effectiveness of using HPV nine-valent vaccine in people over 26 years old.

　　Hong Kong’s approval of the application for the elderly is mainly based on the effectiveness of the tetravalent vaccine for the elderly population. The nine-valent vaccine and the tetravalent vaccine are immune-bridged, so the application range is 9-45 years old.

　　— — Is it still useful to vaccinate married and fertile women?

　　Some married and fertile women have not been infected by the virus, or have not been infected by the HPV subtype contained in the vaccine. At this time, vaccination is also effective.

　　— — How many times does the vaccine need to be vaccinated?

　　The bivalent, tetravalent and nonavalent vaccines all need to be injected in three times and completed within six months.

　　Among them, bivalent vaccine is recommended to be inoculated in October, January and June, with a total of 3 doses. The second dose can be inoculated 1-2.5 months after the first dose, and the third dose can be completed 5-12 months after the first dose.

　　Four-valent and nine-valent vaccines are recommended to be vaccinated in October, February and June, with a total of three doses. The interval between the first dose and the second dose should be at least one month, and the interval between the second dose and the third dose should be at least three months. All three doses should be completed within one year.

　　— — Is it still necessary to vaccinate with nine valence after vaccination with four valence?

　　At present, there is not enough evidence to prove that it will be more beneficial to vaccinate another series after completing one series of vaccines.

　　From the clinician’s point of view, women who have been vaccinated with one of bivalent, tetravalent and nonavalent vaccines and completed all injections can prevent more than 70% of cervical cancer. Another HPV vaccine injection is not recommended.

　　The instructions for the nine-valent vaccine mentioned that after the third dose of tetravalent HPV vaccine was inoculated, the nine-valent vaccine was injected at least 12 months apart.

　　— — How long is the vaccine valid?

　　Bivalent and tetravalent vaccines have been on the market for more than ten years. At present, the research data show that the antibody level of the vaccinated population is still at a high level, and there is no evidence that it is necessary to strengthen vaccination.

　　The nine-valent vaccine was launched in 2014. Studies on people aged 9-15 and 16-26 showed that serum antibodies remained positive in the fifth year after vaccination. At present, there is no evidence of the need for intensive vaccination.

　　— — What tests should I do before vaccination?

　　No special examination is needed before vaccination. However, in my personal opinion, people who have been sexually exposed and have never been screened for cervical cancer before should be screened. The purpose of screening is to know whether they have cervical lesions.

　　— — Which groups are not suitable for vaccination?

　　People who are allergic to the active ingredients used in the vaccine or any dressing adjuvant should be prohibited from using it. People who have had hypersensitivity after injecting HPV vaccine should not be vaccinated again.

　　In addition, women who are pregnant and pregnant are not recommended to be vaccinated now. Although a large number of practices that have been put on the market have proved that there is no data showing that the vaccine will affect the growth and development of embryos, pregnancy preparation and pregnancy are special periods, so it is not recommended for such people to be vaccinated immediately.

　　— — What are the side effects of the vaccine?

　　At present, the safety of the vaccine is still very good. Vaccination of this kind of vaccine is the same as other vaccines. The common systemic adverse reactions are mainly headache, fever, nausea and dizziness, and the local adverse reactions are mainly pain, swelling, erythema and itching.

　　— — Can men be vaccinated?

　　At present, all vaccines approved in China are used by women to prevent cervical cancer.

　　In foreign countries, tetravalent vaccines approved by some countries can be used for male vaccination. Male vaccination can also prevent precancerous lesions of some reproductive organs, condyloma and so on.

　　In addition, male vaccination is beneficial to the emergence of group immune effect, which reduces the overall infection rate of HPV virus in the population.

　　— — What are the precautions for preventing cervical cancer?

　　To prevent cervical cancer, in addition to vaccination, regular screening should be conducted, especially for women who have had sexual exposure.

　　For healthy people under the age of 30, it is suggested that only cell screening should be carried out. If the screening result is negative, it can be checked again after 3 years. For healthy people over 30 years old, it is recommended to carry out cell screening and HPV virus examination. If the results are double negative, they can be examined again after 5 years.

　　Early sexual exposure, many sexual partners, active sexual behavior and unclean sexual behavior are all high risk factors for cervical cancer, so condoms are recommended for safe sex. In addition, developing a healthy lifestyle is also beneficial to the prevention of diseases.

　　If you retire in 20-30 years, how much pension can you expect to receive? The official data is coming! Yesterday, the national social insurance public service platform was put into trial operation. According to the experience of Beijing Youth Daily reporter, the platform not only needs to input relevant data such as my monthly payment salary and actual payment years, but also has three unknown variables such as "average salary growth rate of employees in the future (%)", "future personal account bookkeeping interest rate (%)" and "future payment salary growth rate (%)", so the calculation is not the actual pension amount, but more a scientific prediction for the future.

　　The official helps you predict how much pension you will receive.

　　The national social insurance public service platform (http://si.12333.gov.cn) has been put into trial operation. The platform can provide social security annual enrollment information inquiry, treatment qualification authentication, pension calculation, social security relationship transfer inquiry, remote medical inquiry, overseas exemption application, social security card and electronic social security card status inquiry, etc., all of which are national and cross-regional services.

　　The website platform provides two registration methods, one is according to the ID number, and the other is according to the social security card and social security bank card.

　　The reporter login test of Beiqing Daily takes only 1 minute, which is convenient and quick, from inputting information to inputting mobile phone number, waiting for receiving SMS password and completing registration.

　　The registered login successfully entered the column of "Pension Calculation", and the webpage of "Calculation of Pension Insurance Benefits for Urban Employees" was displayed. You can select "Employees of Urban Enterprises", "Individual Industrial and Commercial Households or Flexible Employed Persons" according to the insured type, and the data can be automatically predicted.

　　According to the information entered in the dialog box, the reporter of Beiqing Daily took a 40-year-old man as an example. The expected retirement age was 60 years, and the actual payment period was 15 years, which was deemed as the payment period of 15 years. At the end of last year, the personal account deposit was 180,000 yuan, and the average monthly salary of employees in the insured place (Beijing) last year was 8,467 yuan (released by the Statistics Bureau), and my monthly salary was 10,000 yuan, while "the average salary growth rate of employees in the future (%)" and According to systematic calculation, a 40-year-old man with a monthly income of 10,000 yuan will retire in 2039, with a monthly basic pension of 22,217 yuan.

　　What is the "personal account bookkeeping interest rate"

　　It is worth noting that the substitution of the three variables about future expectations will have a great impact on the prediction of future pensions.

　　Let’s take a 30-year-old man as an example. He is expected to work until he is 60 years old, and his monthly salary is 20,000 yuan. If the average wage growth rate of employees in the future (%) and the future contribution wage growth rate (%) are 10% and 5% respectively, he may have a pension in the future by substituting 3%, 5% and 8% into the future personal account charging rate (%). That is to say, when retiring in 2049, the insured person’s expected monthly basic pension is about 59,000 yuan to 71,800 yuan.

　　"Bookkeeping interest rate of personal account" directly affects the amount of future pension. The General Office of the Ministry of Human Resources and Social Security and the General Office of the Ministry of Finance issued the "Notice on Announcing the Bookkeeping Interest Rate of Personal Accounts of Basic Endowment Insurance for Employees in 2018", which announced that the bookkeeping interest rate of personal accounts of basic endowment insurance for urban employees (including basic endowment insurance for government institutions and enterprise employees) was 8.29% in 2018.

　　Bank time deposit interest rate in 2018: one-year fixed annual interest rate is 1.75%, and three-year fixed annual interest rate is 2.75%; The average yield of some bank wealth management products is about 4%. This means that under the same principal, the interest income of personal account of endowment insurance is 4.73 times that of regular deposit in the bank for one year and 2.03 times that of purchasing bank wealth management products.

　　The Ministry of Human Resources and Social Security pointed out that the bookkeeping interest rate of individual accounts for employees’ basic old-age insurance is announced by the Ministry of Human Resources and Social Security and the Ministry of Finance every year. The determination of bookkeeping interest rate mainly considers factors such as employee salary growth and fund balance, and is adjusted through reasonable coefficients, which shall not be lower than the bank time deposit interest rate.

　　The reporter of Beiqing Daily noted that in 2016 and 2017, the bookkeeping interest rates of personal accounts of basic old-age insurance for urban employees (including basic old-age insurance for government institutions and enterprise employees) were 8.31% and 7.12%, respectively, which were much higher than the deposit interest rates of banks in the same period.

　　There are also functions such as querying the status of social security cards.

　　It is reported that the platform will first provide the functions of social security annual enrollment information inquiry, treatment qualification authentication, pension calculation, social security relationship transfer inquiry, medical consultation in different places, overseas exemption application, social security card and electronic social security card status inquiry, etc., to achieve nationwide cross-regional services.

　　At present, 25 provinces have completed the docking of some areas with the national social insurance public service platform, and 22 provinces provide pension insurance benefits calculation services. Among them, 13 provinces will also provide personalized measurement services.

　　Data show that by the end of June, the number of people participating in basic pension, unemployment and work-related injury insurance in China was 947 million, 200 million and 245 million respectively, an increase of 4.43 million, 3.28 million and 6.5 million respectively over the end of last year.

　　Text/reporter Yan Lishuang

　　Coordinator/Yu Meiying

　　BEIJING, Oct. 9 (Xinhua)-Talking about the reform of clinical trial management, Wang Zhexiong, director of the china food and drug administration Medical Device Registration Department, said today that he will jointly introduce the filing conditions and filing management measures for clinical trial institutions with the National Health and Family Planning Commission, establish a filing management information system for clinical trial institutions and clinical trial projects, strengthen supervision and inspection, and severely investigate and punish illegal acts of practicing fraud and fabricating clinical trial data during clinical trials.

　　On October 8th, the General Offices of the General Office of the Central Committee of the CPC and the State Council issued the Opinions on Deepening the Reform of Review and Approval System and Encouraging the Innovation of Medicines and Medical Devices, with a total of 36 articles in six parts. China food and drug administration held a press conference today to introduce the reform of drug and medical device examination and approval and encourage innovation, and to answer questions from reporters.

　　Wang Xiongxiong said that in 2014, the Food and Drug Administration issued the "Special Approval Procedure for Innovative Medical Devices (Trial)", which included innovative products with China’s invention patents, independent intellectual property rights, domestic pioneering technology, international leading level and significant clinical application value in special approval channels. At present, 29 products have been approved for marketing.

　　In 2016, the Food and Drug Administration issued the Priority Approval Procedure for Medical Devices, which included the products listed in the national major projects or key research and development plans, including the treatment of rare diseases, malignant tumors, diseases unique to the elderly and frequent diseases, including children’s special medical devices into the priority approval procedure. At present, eight products have been included in the priority approval scope. By innovating the special examination and approval of medical devices and giving priority to the examination and approval of medical devices, the trauma of operation is reduced, the diagnosis and treatment needs of special patients are met, the probability of early detection of diseases is improved, and the timely treatment of patients in the later period is ensured. The listing of these products provides clinicians with choices, reduces clinical costs through the supply of products, and makes patients feel the benefits of reform.

　　This time, the Central Office and the State Council issued opinions on deepening reform and encouraging innovation, and will carry out the following work in the reform of medical device review and approval.

　　The first is to reform the management of clinical trials.The filing conditions and filing management measures of clinical trial institutions will be jointly promulgated with the National Health and Family Planning Commission, the filing management information system of clinical trial institutions and clinical trial projects of medical devices will be established, and the supervision and inspection of clinical trial institutions and clinical trial projects will be strengthened. Illegal acts of practicing fraud and fabricating clinical trial data during clinical trials will be severely investigated and punished according to law.

　　For medical devices that are seriously life-threatening and have no effective treatment methods, the initial observation in clinical trials may benefit, allowing them to be used by other patients after informed consent through extended clinical trials, and the corresponding data can be used for the registration application of medical devices. At the same time, the clinical trial review and approval of medical devices will be changed from express permission to implied permission to improve efficiency.

　　The second is to speed up the review and approval of medical devices listed.Receive overseas clinical trial data that meet the requirements of China’s medical device registration regulations when registering medical devices, and at the same time, scientifically and reasonably set relevant requirements for clinical evaluation of medical devices, speed up the examination and approval of medical devices that are urgently needed in clinic, and reduce clinical trials for medical devices with rare diseases, and grant conditional approval for listing. There is no effective treatment for diseases that seriously endanger life, and medical devices that are urgently needed in public health can also be approved for marketing with conditions attached. Priority will continue to be given to the review and approval of innovative medical devices supported by major national science and technology projects and key national R&D plans.

　　The third is to improve the examination and approval system of medical devices and strengthen the capacity building of medical device evaluation institutions.Form a new review and approval system with review as the leading factor and inspection, testing and evaluation as the support. Carry out team review, establish a project review team composed of reviewers from clinical medicine, clinical diagnosis, machinery, electronics, materials and biomedical engineering, and be responsible for the review of innovative products.

　　Constantly improve the communication mechanism between registered applicants and the evaluation center, strictly implement the expert advisory Committee system, and demonstrate major technical issues by the expert advisory Committee. We will promote the registration and evaluation of medical devices to be included in the pilot scope of government-purchased services. Through this measure, we will increase the number of reviewers and expand the team of reviewers. At the same time, we will strengthen the training of reviewers, improve their quality and establish a professional team of reviewers. The documents of the two offices also mentioned that it is necessary to actively promote the unification of the evaluation standards for Class II medical devices and gradually realize the unified national evaluation.

　　Fourth, implement the life cycle management of medical devices, strengthen the construction of inspectors, gradually establish a professional inspector team, strengthen the training of inspectors, and improve the ability and level of inspectors.Strengthen the supervision and inspection of the implementation of quality management standards for clinical trials and production quality management standards for medical devices. In this process, we should gradually improve the system of medical device registrants, and implement the legal responsibilities of registrants in the whole process and life cycle of medical device design and development, clinical trials, manufacturing, sales and distribution, product recall, adverse event reporting and re-evaluation.

　　Wang Xiongxiong said that through the above measures, medical device innovation will be further encouraged to meet the needs of clinical use, stimulate the development vitality of China’s medical device industry, and promote the healthy and rapid development of China’s medical device industry.

There was a new model in February, which attracted the attention of many consumers. The new car is. As a medium-sized SUV, the price is not high, 162,800 yuan and 175,800 yuan.

In addition, these two new cars have good advantages, for example, all of them have intelligent assisted driving systems, and all of them have openable panoramic sunroof, 1.5T plus plug-in hybrid, and the power engine is exactly the same in high and low models. At the same time, this new car also has obvious advantages and disadvantages. In order to let our friends know the new car more clearly, we listed it.

The first advantage is naturally the hard-core off-road appearance. The so-called face value is justice. The face value of this Haval second-generation big dog PHEV is really easy to poke the hearts of consumers.

The appearance of the new car adopts a retro hard-core design, and the lines of the whole car body are particularly straight and have a strong sense of strength. In addition, the minimum ground clearance of the new car has reached 200mm, the hard-core off-road appearance and strong passability are all the designs that this new car is most likely to hit consumers.

The second advantage is the interior design of the new car. The size of the central control screen has reached 14.6 inches, with abundant vehicles and exquisite screen display, and it also has many network connection systems to support voice recognition control systems. For young consumers, this design is very powerful. But at the same time, if the friends who have adapted to the physical buttons need to practice more, otherwise it is more dangerous to touch the screen during driving, and there is basically no blind exercise.

The third advantage is the interior space. The length, width and height of the new car are 4705/1908/1780mm respectively, and the wheelbase is 2810mm. After all, it is very rare to want a new car with a width of more than 1.9 meters and a wheelbase of more than 2.8 meters at this price. The seating space in the car is relatively spacious, the seats in the front and rear rows are relatively long, and the support for the legs is sufficient, so there is no feeling of hanging or sitting on a small bench.

The extra-long interior space makes the trunk even more excellent, up to 483L L. If the rear seat is put down, it can be extended to 1362L, and the second row of seats is flat after being put down.

The fourth advantage lies in the power system of the new car. The second-generation big dog PHEV of Haval adopts a plug-in hybrid consisting of 1.5T and a motor, with a comprehensive torque of 530N·m, a comprehensive endurance of 1000km and a low fuel consumption. More importantly, the Haval second-generation big dog PHEV has four wheels, which not only has lower fuel consumption, but also has a good driving experience. The curb weight of the new car is about two tons, so the stability of the car body is ideal during high-speed driving.

At the same time, this new car also has several shortcomings.

The first shortcoming is the appearance of this new car. As an SUV with a relatively off-road shape, it is reasonable to hang a spare tire at the rear. This off-road atmosphere is better, but it is a pity that this new car does not. The main reason is that this Haval second-generation big dog PHEV doesn’t have a spare tire at all, only tire repair liquid. If you go to the country by car, this design is more worrying.

The second shortcoming is that although the new car has its own rich network connection system, it is used more in our daily life and does not appear in this new car.

The third deficiency is that the car machine system of the Great Wall is relatively closed. At present, there is no way to freely download third-party APPs, and there are too few apps that can be downloaded in the app store. This is obviously compared with and or various new forces in car making. Contrast.

The fourth deficiency is that the entry-level model has no fast charging function. The reason why we can save money is largely because the electricity bill at home at night is relatively cheap, and the entry-level version of Haval’s second-generation big dog PHEV has no fast charging function, so there is naturally no way to install household charging piles.

Of course, for a medium-sized SUV, the starting price of 162,800 yuan is still very fragrant, but can you accept it?